Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Nortec Quimica
Deal Size : Undisclosed
Deal Type : Partnership
Fiocruz and Nortec Quimica Launch Partnership Against Chagas Disease
Details : The partnership aims to improve the production of the active pharmaceutical ingredient (API) of benznidazole, the only drug used in Brazil for the Chagas disease.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
February 05, 2023
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Nortec Quimica
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Drugs for Neglected Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 21, 2021
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Drugs for Neglected Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Chemo Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 18, 2019
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Chemo Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : PhinC Development
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetic Drug-Drug Interaction Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 27, 2019
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : PhinC Development
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : National Council of Scientific Research, Argentina | Pan American Health Organization | Becas Carrillo Oñativia, Ministerio de Salud, Argentina | Drugs for Neglected Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 11, 2015
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : National Council of Scientific Research, Argentina | Pan American Health Organization | Becas Carrillo Oñativia, Ministerio de Salud, Argentina | Drugs for Neglected Diseases
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Population Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas Disease
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 24, 2012
Lead Product(s) : Benznidazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable